Pediatric Research, 2025
Gut microbiota, inflammatory cytokines, and Kawasaki disease: a Mendelian randomization study and mediation analysis

Wang J., Dou H., Liang Q.

Nature Genetics, 2025
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups

Hoffmann T., Graff R., Madduri R. et al.

Nature Communications, 2025
Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom’s Macroglobulinemia

Sklavenitis-Pistofidis R., Konishi Y., Heilpern-Mallory D. et al.

Frontiers in Endocrinology, 2025
Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid

Wang C., Feng Y., Chen Y. et al.

Journal of Stroke and Cerebrovascular Diseases, 2025
Exploring the bidirectional relationships between alzheimer's disease and cerebral small vessel disease: Insights from mendelian randomization

Shang H., Liu T., Gong W. et al.

Brain Communications, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis

van Eijk R., Steyn F., Janse van Mantgem M. et al.

Arthritis Research & Therapy, 2025
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype

Xu X., Qiu T., Sun K. et al.

International Journal of Chronic Obstructive Pulmonary Disease, 2025
The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD

Yan K., Wang Y., Xin P.

Movement Disorders, 2025
Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [¹¹C]PBR28 PET

Wallin J., Forsberg A., Svenningsson P.

ImmunoTargets and Therapy, 2025
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy

Ke C., Yu Y., Li J. et al.

Journal for ImmunoTherapy of Cancer, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights

Wang X., Tian H., Chi Z. et al.

eBioMedicine, 2025
Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

Michaëlsson K., Zheng R., Baron J. et al.

Nature Cardiovascular Research, 2025
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction

Rasooly D., Giambartolomei C., Peloso G. et al.

Translational Vision Science & Technology, 2025
Genetics of Circulating Inflammatory Proteins and Iridocyclitis: An Exploratory Mendelian Randomization Study

Liu H., Li F., Wang F. et al.

Nature, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

Braun D., Moranzoni G., Chea V. et al.

Cell Death Discovery, 2025
Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells

Hajikhezri Z., Zygouras I., Sönnerborg A. et al.

Scientific Reports, 2025
Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy

Zhang R., Chang R., Wang H. et al.

Journal of Ethnopharmacology, 2025
Lianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms

Jin P., Qi H., Zhao J. et al.

Clinical Cancer Research, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma

Till J., Seewald N., Yazdani Z. et al.

Nature Medicine, 2025
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection

Duff E., Zetterberg H., Heslegrave A. et al.